Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 7, 2016
The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study
Marliese Alexander, Sue M Evans, Robert G Stirling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 9, 2010
Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method
Michael Bayne, Rodney J Hicks, Sarah Everitt, et al.
Cancers
|
January 11, 2019
Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer
Marliese Alexander, David Ball, Benjamin Solomon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning
Belinda A Campbell, Jason Callahan, Mathias Bressel, et al.
British Journal of Haematology
|
April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?
Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
Cancer
|
July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer
Sarah Everitt, Alan Herschtal, Jason Callahan, et al.
Journal of Medical Imaging and Radiation Oncology
|
July 28, 2021
Nodal metabolic tumour volume on baseline <sup>18</sup> F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapy
Ramin Alipour, Nick Bucknell, Mathias Bressel, et al.
Plos One
|
November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
Shu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 10, 2013
Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases
Shankar Siva, Tomas Devereux, Tomas Kron, et al.
Leukemia & Lymphoma
|
April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P Ng, Andrew Wirth, John F Seymour, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 7, 2016
The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study
Marliese Alexander, Sue M Evans, Robert G Stirling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 9, 2010
Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method
Michael Bayne, Rodney J Hicks, Sarah Everitt, et al.
Cancers
|
January 11, 2019
Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer
Marliese Alexander, David Ball, Benjamin Solomon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2015
Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning
Belinda A Campbell, Jason Callahan, Mathias Bressel, et al.
British Journal of Haematology
|
April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?
Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
Cancer
|
July 13, 2010
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer
Sarah Everitt, Alan Herschtal, Jason Callahan, et al.
Journal of Medical Imaging and Radiation Oncology
|
July 28, 2021
Nodal metabolic tumour volume on baseline <sup>18</sup> F-FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative-intent chemoradiotherapy/radiotherapy
Ramin Alipour, Nick Bucknell, Mathias Bressel, et al.
Plos One
|
November 25, 2015
Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
Shu Wen Wen, Sarah J Everitt, Justin Bedő, et al.
Journal of Medical Imaging and Radiation Oncology
|
October 10, 2013
Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases
Shankar Siva, Tomas Devereux, Tomas Kron, et al.
Leukemia & Lymphoma
|
April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
Ashley P Ng, Andrew Wirth, John F Seymour, et al.
Page
of 8